RBC Capital Markets initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

The companies continue to work to secure Lyumjev compatibility for the t:slim X2 pump in other regions and to secure Lyumjev compatibility for the Tandem Mobi pump. Please see Lyumjev Full ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) ...

t:slim X2 Insulin Pump from Tandem Diabetes Care with Abbott’s Freestyle Libre 2 Plus sensor. [Image courtesy of Abbott/Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) announced today that it ...

RBC sets a $65 price target for Tandem, citing strong growth prospects and margin improvements. RBC expects 51% gross margins in 2024, with the Mobi pump launch driving long-term profitability.

Heat pump furnace combos, commonly known as dual-fuel or hybrid systems, consist of an electric heat pump and a furnace ...

Tandem Diabetes Care Inc (TNDM) reports a robust 12% sales growth in Q2 2024, driven by successful product launches and ...

Analyst Jeff Johnson from Robert W. Baird reiterated a Hold rating on Tandem Diabetes Care (TNDM – Research Report) and increased the ...